Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The games drug companies play can dramatically raise costs for patients

Rob Lamberts, MD
Physician
February 14, 2016
Share
Tweet
Share

I had a patient last week who was a real pain in the ass.  Wait.  No.  He was actually a really nice guy.  He wasn’t a pain in the ass; he had a real pain in the ass.  Literally.

I was initially concerned about a pilonidal cyst, given the unfortunate fact that he was previously afflicted with this condition (which I consider to be incontrovertible proof of Satan).  But, fortunately to him, his pain was literally “in the ass,” and that rules out the evil diagnosis, moving my thoughts to a condition called proctalgia fugax (which is a Latin person’s way of saying: “butt pain that comes and goes”).

I realize this doesn’t sound much like good news on my patient’s part, but, as opposed to the lousy surgery necessary for treatment of a pilonidal cyst, an effective treatment for this is fairly simple (and surprising): nitroglycerin ointment applied to the rectum.  Nitroglycerin, it turns out, relaxes smooth muscles and dilates blood vessels, both of which somehow can improve the distressing symptoms of this strange condition (as well as pain from other related proctological demonic attacks).  I’m not sure who had the idea to first try this, or what their inspiration was.  Perhaps they misheard the term angina pectoris as angina rectalis.

I did my usual search at GoodRx.com (a website everyone should use as often as possible) to see where the drug is cheapest.  It turns out that Kroger won the contest, but the price was $479.  According to the literature, the appropriate strength of nitroglycerin for rectal use (cleverly called “Rectiv”) is 0.4 percent.  This seemed a pretty high price for a medication which has long been generic, so I searched for generic nitroglycerin ointment (used for pain due to heart disease) and found it for $35 at Walmart.  The only difference between the two that I can tell is that that preparation (called NitroBid) is 2 percent.

NitroPrices

There are several possible explanations for this huge price discrepancy:

  1. The dilution of nitroglycerin is a dangerous and expensive process, as it is quite explosive.
  2. The cost of coming up with the name “Rectiv” by the marketing department was extremely high.  It is far more clever than NitroBid, to be sure.
  3. There is a secret ingredient in Rectiv that raises the cost.  Perhaps they have to get anal secretions from unicorns.

While these seem reasonable, I suspect a different reason: The company which makes Rectiv, Allergan (which also makes Botox), has cornered the market on 0.4 percent nitroglycerin, and so can charge exorbitant amounts for a medication with no other discernible reason to be expensive (it certainly took little R&D cost, and doesn’t regularly get advertised during the evening news).

I’m sure my anally distressed patient would have paid $1,000 for relief, but this wasn’t my first ride at the proctalgia rodeo (which has recently been nominated as an Olympic event), and I knew he could use the more potent cheaper version with the boring name (and has nothing to do with unicorns) without problems.  He did, and he got immediate relief.  Now, like Androcles, I have someone who owes me a great debt for my kindness and wisdom.

This incident is just one example of the terrible gaming that routinely occurs with the prices of drugs.  There are plenty of others. Why, for example, do brand name medications continue having such high prices after the medication has gone generic (often 10 to 20x higher)?  The reason is, if the generic no longer available, they get a cash windfall.

For example, Carafate (a medication for stomach ulcers) went generic a many years ago and so you can get 120 tablets of the generic for $33.

2016-01-29+03.18.41+pm

But recently the suspension form (which I’ve used for mouth ulcers and esophageal problems) became unavailable as a generic and so now is only available as the brand name drug.  The result is that the once inexpensive suspension now comes with a premium price tag:

2016-01-29+03.19.53+pm

Note that this price is for 420 mL, which is the equivalent of 42 tablets, so the markup is more than 10-fold.

Pharmacies join in on the price gaming by pricing one drug much lower than competitors, while going way higher than the market on others.  Generic Topamax (a drug used for seizures and migraine prevention), for example, costs $11 at Publix and $68 at Rite Aid.

2016-01-29+03.14.54+pm

ADVERTISEMENT

So should you go to Publix for all of your medications?  Unfortunately, if you get your Topamax with a Lipitor chaser, the generic cholesterol drug costs more than $90 at Publix, where it’s much cheaper at other pharmacies.

2016-01-29+03.15.53+pm

All pharmacies do this, in my experience, so you can’t count on anyone pharmacy to have cheap prices.  To get inexpensive medications, you must shop around and be willing to go to multiple pharmacies for multiple medications.  It’s a game they play that usually works, as most folks either don’t know about this, or they just don’t want to bother going to multiple pharmacies.

These games come at a great cost, dramatically raising the cost of care for millions of Americans.  It is legal.  It is done all the time.  And it is gouging.  And this gouging isn’t unique to the pharmaceutical industry, as labs and radiology providers have their tricks to make enormous profit margins on the services they provide.

Fortunately for this my patient, I was not only able to reunite him with the joys of sitting, but I was able, with a little research, to find him his proctological savior at a low cost.  Unfortunately, most patients don’t have docs who are economically incentivized to save them money, and most people don’t realize all of the games played by pharmaceutical companies and pharmacies to routinely perform wallet biopsies, nor do they know how to find the cheapest prices for their medications.

I don’t know what can be done about this kind of thing aside from increasing awareness. I’m not real confident in any government solution.  People just need to be smarter shoppers when it comes to their care.  It’s just a shame that people who are dealing with health problems (even if it is just trouble sitting) have to outsmart the gaming done by those supposedly trying to help them.

Rob Lamberts is an internal medicine-pediatrics physician who blogs at Musings of a Distractible Mind.

Image credit: Shutterstock.com

Prev

When it comes to positive change, physicians are their own worst enemy

February 14, 2016 Kevin 12
…
Next

Physicians can make a difference. Here are 3 ways they did.

February 14, 2016 Kevin 20
…

Tagged as: Medications, Primary Care

Post navigation

< Previous Post
When it comes to positive change, physicians are their own worst enemy
Next Post >
Physicians can make a difference. Here are 3 ways they did.

ADVERTISEMENT

More by Rob Lamberts, MD

  • How the lack of coronavirus testing impacts primary care

    Rob Lamberts, MD
  • Welcome to prior-authorization hell

    Rob Lamberts, MD
  • We must find a way to reward doctors who are caring and compassionate

    Rob Lamberts, MD

Related Posts

  • Crippling drug costs: the role of insurers

    Janice Boughton, MD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Are patients using social media to attack physicians?

    David R. Stukus, MD
  • Drug price hikes sometimes have catastrophic effects on patients

    Zoe Tseng, MD and Suhas Gondi
  • You are abandoning your patients if you are not active on social media

    Pat Rich
  • A love letter to patients

    Marcie Costello

More in Physician

  • Why more doctors are choosing direct care over traditional health care

    Grace Torres-Hodges, DPM, MBA
  • How to handle chronically late patients in your medical practice

    Neil Baum, MD
  • How early meetings and after-hours events penalize physician-mothers

    Samira Jeimy, MD, PhD and Menaka Pai, MD
  • Why medicine must evolve to support modern physicians

    Ryan Nadelson, MD
  • Why listening to parents’ intuition can save lives in pediatric care

    Tokunbo Akande, MD, MPH
  • Finding balance and meaning in medical practice: a holistic approach to professional fulfillment

    Dr. Saad S. Alshohaib
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 16 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The games drug companies play can dramatically raise costs for patients
16 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...